APA (7th ed.) Citation

Bellone, M., Sabinot, A., D’Arpino, A., Salè, E. O., Ghislieri, D., & Pradelli, L. A 1-year per-patient cost of therapy administration analysis of mosunetuzumab and tisagenlecleucel in relapsed or refractory follicular lymphoma patients receiving two or more lines of systemic therapy. AboutScience Srl.

Chicago Style (17th ed.) Citation

Bellone, Marco, Alice Sabinot, Alessandro D’Arpino, Emanuela Omodeo Salè, Daniela Ghislieri, and Lorenzo Pradelli. A 1-year Per-patient Cost of Therapy Administration Analysis of Mosunetuzumab and Tisagenlecleucel in Relapsed or Refractory Follicular Lymphoma Patients Receiving Two or More Lines of Systemic Therapy. AboutScience Srl.

MLA (9th ed.) Citation

Bellone, Marco, et al. A 1-year Per-patient Cost of Therapy Administration Analysis of Mosunetuzumab and Tisagenlecleucel in Relapsed or Refractory Follicular Lymphoma Patients Receiving Two or More Lines of Systemic Therapy. AboutScience Srl.